scispace - formally typeset
S

Susan Solliday Rich

Researcher at Baylor College of Medicine

Publications -  43
Citations -  3196

Susan Solliday Rich is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: T cell & Lymphocyte. The author has an hindex of 20, co-authored 43 publications receiving 3168 citations. Previous affiliations of Susan Solliday Rich include Mayo Clinic & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1

TL;DR: In this article, gene targeting was used to produce mice deficient in intercellular adhesion molecule 1 (ICAM-1) or CD54, an immunoglobulin-like cell adhesion molecules that binds beta 2 integrins.
Journal ArticleDOI

pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells.

TL;DR: Fyn- thymocytes were impaired at a late stage of maturation and showed limited clonal deletion to the Mls-1a self-super-antigen but not to staphylococcal enterotoxin A, implicate fyn as a critical component in TCR signaling in thymocyte and, potentially, in the process that determines T cell repertoire in the adult mouse.
Journal ArticleDOI

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice

TL;DR: Gαi2–deficient mice display growth retardation and develop a lethal diffuse colitis with clinical and histopathological features closely resembling ulcerative colitis in humans, including the development of adenocarcinoma of the colon.
Journal ArticleDOI

Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice

TL;DR: A severe defect in T cell proliferation was found in the CD18 null mice when T cell receptors were stimulated either by staphylococcal enterotoxin A or by major histocompatibility complex alloantigens demonstrating a greater role of CD11/CD18 integrins in Tcell responses than previously documented.
Journal ArticleDOI

Combination gene therapy for liver metastasis of colon carcinoma in vivo

TL;DR: The results suggest that combination suicide and cytokine gene therapy in vivo can be a powerful approach for treatment of metastatic colon carcinoma in the liver.